Literature DB >> 11145010

Ultrastructural study of the ventral lobe of the prostate of mice with streptozotocin induced diabetes (C57BL/6J).

V H Cagnon1, A M Camargo, R M Rosa, R Fabiani, C R Padovani, F E Martinez.   

Abstract

Morphological and functional changes caused by diabetes in the accessory sex organs and especially the prostate have been reported by several investigators. The aim of the present study was to examine the possible deleterious effects of experimentally induced diabetes on the secretory epithelium of the ventral prostate of mice. Sixteen adult male C57BL/6J mice were divided into two groups. The diabetic group received a streptozotocin injection of 75 mg/kg, while the control group received only 0.1 ml citrate buffer, i.p. After 30 days, the diabetic state was ascertained, the animals were sacrificed and the ventral lobe of the prostate was collected for histological and ultrastructural examination. The results showed reduction in glandular epithelium cell height, increased numbers of cytoplasmic vacuoles and thickening of the extracellular matrix. In conclusion, experimental diabetes has harmful effects on the secretory epithelial cells of the ventral lobe of the prostate of mice.

Entities:  

Mesh:

Year:  2000        PMID: 11145010     DOI: 10.1054/tice.2000.0123

Source DB:  PubMed          Journal:  Tissue Cell        ISSN: 0040-8166            Impact factor:   2.466


  9 in total

1.  Diabetes induces stromal remodelling and increase in chondroitin sulphate proteoglycans of the rat ventral prostate.

Authors:  Daniele Lisboa Ribeiro; Sebastião Roberto Taboga; Rejane Maira Góes
Journal:  Int J Exp Pathol       Date:  2009-08       Impact factor: 1.925

2.  Proliferation and apoptotic rates and increased frequency of p63-positive cells in the prostate acinar epithelium of alloxan-induced diabetic rats.

Authors:  Fanny Oliveira Arcolino; Daniele Lisboa Ribeiro; Marina Guimarães Gobbo; Sebastião Roberto Taboga; Rejane Maira Góes
Journal:  Int J Exp Pathol       Date:  2009-12-22       Impact factor: 1.925

3.  Malignant lesions in the ventral prostate of alloxan-induced diabetic rats.

Authors:  Daniele Lisboa Ribeiro; Silvio Fernando Guideti Marques; Sandra Alberti; César Tadeu Spadella; Antônio José Manzato; Sebastião Roberto Taboga; Nishtman Dizeyi; Per-Anders Abrahamsson; Rejane Maira Góes
Journal:  Int J Exp Pathol       Date:  2008-08       Impact factor: 1.925

4.  Reduction of insulin signalling pathway IRS-1/IRS-2/AKT/mTOR and decrease of epithelial cell proliferation in the prostate of glucocorticoid-treated rats.

Authors:  Maitê M Costa; Natália M Violato; Sebastião R Taboga; Rejane M Góes; José R Bosqueiro
Journal:  Int J Exp Pathol       Date:  2012-06       Impact factor: 1.925

5.  Dystroglycan patterns on the prostate of non-obese diabetic mice submitted to glycaemic control.

Authors:  Valéria Helena Alves Cagnon; Valéria Helena Alves Cagnon Quitete; Wagner José Fávaro
Journal:  Int J Exp Pathol       Date:  2009-04       Impact factor: 1.925

6.  Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions.

Authors:  Marina G Gobbo; Nishtman Dizeyi; Per-Anders Abrahamsson; Per-Anders Bertilsson; Viviane Sanches Masitéli; Eloisa Zanin Pytlowanciv; Sebastião R Taboga; Rejane M Góes
Journal:  J Diabetes Res       Date:  2015-07-30       Impact factor: 4.011

7.  A protective role of arecoline hydrobromide in experimentally induced male diabetic rats.

Authors:  Indraneel Saha; Joydeep Das; Biswaranjan Maiti; Urmi Chatterji
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411

8.  Ventral prostate fibrosis in the Akita mouse is associated with macrophage and fibrocyte infiltration.

Authors:  Sanghee Lee; Guang Yang; William Mulligan; Jerry Gipp; Wade Bushman
Journal:  J Diabetes Res       Date:  2014-06-11       Impact factor: 4.011

9.  Ginger Ingredients Alleviate Diabetic Prostatic Complications: Effect on Oxidative Stress and Fibrosis.

Authors:  Basma G Eid; Hala Mosli; Atif Hasan; Hany M El-Bassossy
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-17       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.